K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers

Pathology International

Volumn 49, Issue 1, 1999, Pages 30-37

  Itoi, Takao ^a   Takei, Kazuo ^b   Shinohara, Yasushi ^b   Takeda, Kazuya ^a   Nakamura, Kazuto ^b   Horibe, Toshiya ^b   Sanada, Atsushi ^b   Ohno, Hiroyuki ^b   Matsubayashi, Hiroyuki ^b   Saito, Toshihiko ^b   Watanabe, Hidenobu ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

Bile; Biliary cancer; K ras mutation; p53 mutation

Indexed keywords

PROTEIN P53;

ADENOMYOMATOSIS; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CHOLANGITIS; CHOLECYSTITIS; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUTATION; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032875327     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00821.x     Document Type: Article

References (25)

1. Chen W, Endoh K, Yamamoto M, Kato T. International comparison of the mortalities of biliary tract cancer. J. Aichi Med. Univ. Assoc. 1990; 18: 187-189.
2. Tada M, Omata M, Ohto M. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing. Cancer 1990; 66: 930-935.
3. Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994; 73: 2727-2733.
4. Watanabe M, Asaka M, Tanaka J, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994; 107: 1147-1153.
5. Wistuba II, Sugio K, Kishimoto Y et al. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile. Cancer Res. 1995; 55: 2511-2515.
6. Yoshida S, Todoroki T, Ichikawa Y et al. Mutation of p16Ink4/ CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res. 1995; 55: 2756-2760.
7. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 1996; 77: 452-458.
8. Itoi T, Watanabe H, Yoshikawa T, Ajioka Y, Nishikura K, Saito T. K-ras mutations in gallbladder carcinomas in patients with anomalous arrangement of the pancreaticobiliary duct. Acta Med. Biol. 1996; 44: 71-77.
9. Itoi T, Watanabe H, Ajioka Y et al. APC, K-ras codon 12 mutations and p53 gene expression in carcinoma and adenoma of the gall-bladder suggest two genetic pathways in gall-bladder carcinogenesis. Pathol. Int. 1996; 46: 333-340.
10. Ajiki T, Fujimori T, Onoyama H et al. K-ras gene mutation in gallbladder carcinomas and dysplasia. Gut 1996; 38: 426-429.
11. Wee A, Teh M, Raju GC. Clinical importance of p53 protein in gallbladder carcinoma and its precursor lesions. J. Clin. Pathol. 1994; 47: 453-456.
12. Kamel D, Pääkkö P, Nurova K, Vähäkangas K, Soini Y. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gallbladder. J. Pathol. 1993; 170: 67-72.
13. Takei K, Watanabe H, Itoi T, Saito T. p53 and Ki-67 immunoreactivity and nuclear morphometry of 'carcinoma-in-adenoma' and adenoma of the gall-bladder. Pathol. Int. 1996; 46: 426-435.
14. Lee CS, Pirdas A. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater. J. Pathol. 1995; 27: 117-120.
15. Takagi S, Naito E, Yamanouchi H, Ohtsuka H, Kominato R, Yamamoto M. Mutation of the p53 gene in gallbladder cancer. Tohoku J. Exp. Med. 1994; 172: 283-289.
16. Itoi T, Watanabe H, Yoshida M, Ajioka Y, Nishikura K, Saito T. Correlation of p53 protein expression with gene mutation in gallbladder carcinomas. Pathol. Int. 1997; 47: 525-530.
17. Oohashi Y, Watanabe H, Ajioka Y, Hatakeyama K. p53 immunostaining distinguishes malignant from benign lesions of the gall-bladder. Pathol. Int. 1995; 45: 58-65.
18. Kondo H, Sugano K, Fukayama N et al. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma. Cancer 1994; 73: 1589-1594.
19. Watanabe H, Sawabu N, Ohta H et al. Identification of K-ras oncogene mutations in the pure pancreatic juice of patients with ductal pancreatic cancers. Jpn. J. Cancer Res. 1993; 84: 961-965.
20. Ishimaru S, Itoh M, Hanada K, Ysuchikawa A, Iwao T, Kajiyama G. Immunohistochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 1996; 77: 2233-2239.
21. Lee JG, Leung JW, Cotton PB, Layfield LJ, Mannon PJ. Diagnostic utility of K-ras mutational analysis on bile obtained by endoscopic retrograde cholangiopancreatography. Gastrointest. Endosc. 1995; 42: 317-320.
22. Ajiki T, Onoyama H, Yamamoto M, Fujimori T, Maeda S, Saitoh Y Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary stricture. Int. J. Pancreatology 1995; 18: 215-220.
23. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer, 4th edn. JB Lippincott Co., Philadelphia, 1992.
24. Albores-Saavedra J, Henson DE, Sobin LH. Histological Typing of Tumors of the Gallbladder and Extrahepatic Bile Ducts. World Health Organization. Springer-Verlag, Berlin, 1991.
25. Yanagisawa A, Ohtake K, Ohhashi K et al. Frequent c-K-ras oncogene activation in mucous cell hyperplasia of pancreas suffering from chronic inflammation. Cancer Res. 1993; 53: 953-956.